• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD VERITOR¿ SYSTEM FOR RAPID DETECTION OF FLU A+B CLIA-WAVED KIT; ANTIGENS, CF (INCLUDING CF CONTROL), INFLUENZA VIRUS A, B, C

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD VERITOR¿ SYSTEM FOR RAPID DETECTION OF FLU A+B CLIA-WAVED KIT; ANTIGENS, CF (INCLUDING CF CONTROL), INFLUENZA VIRUS A, B, C Back to Search Results
Model Number 256045
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/24/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd veritor¿ system for rapid detection of flu a+b clia-waved kit discrepant result occurred.The following information is provided by the initial reporter: " customer states they received discrepant results hazard, injury or erroneous results? yes hazard, injury or erroneous results details detailed erroneous results (include # of errors and type): discrepant results what result did the customer obtain from the bd product? customer obtained neg result on initial run what result was the customer expecting to obtain (if different from the obtained result) customer suspected pos results, was this a qc, validation, or proficiency test? patient testing was patient treatment changed as a consequence of the issue with results? yes did the patient suffer any adverse medical consequences as a result of the change in treatment? unknown".
 
Manufacturer Narrative
Investigation summary: this statement is to summarize the investigation results regarding a complaint that alleges received discrepant results when using kit rapid detection of kit flu a+b 30 test physician veritor (material # 256045), batch number 0321884.Bd quality performs a systematic approach to investigate discrepant result complaints.This approach involves review of manufacturing batch history records, testing of retention samples, and testing of customer returned samples, if applicable.An investigation (bhr analysis) was performed on the batch number provided and no relevant issue was found.The retain sample analysis were not performed due to the discrepancy was found to be caused by user error.Communicated to the customer that cartridges are never to be read visually it can be only analyzed by bd veritor analyzer.Review of risk management documentation indicates that the potential risk of the reported complaint (discrepant results) was assessed as severity s3 (reference line # 78) via document ra0002, rev 6.The reported issue was unable to be confirmed.The root cause was identified as cause traced to user.Currently no adverse trend identified for discrepant result.Bd quality will continue to closely monitor for trends.If you have any additional questions or concerns, please do not hesitate to contact bd technical services.
 
Event Description
It was reported that while using bd veritor¿ system for rapid detection of flu a+b clia-waved kit discrepant result occurred.The following information is provided by the initial reporter: " customer states they received discrepant results hazard, injury or erroneous results? yes hazard, injury or erroneous results details detailed erroneous results (include # of errors and type): discrepant results what result did the customer obtain from the bd product? customer obtained neg result on initial run what result was the customer expecting to obtain (if different from the obtained result) customer suspected pos results, was this a qc, validation, or proficiency test? patient testing was patient treatment changed as a consequence of the issue with results? yes did the patient suffer any adverse medical consequences as a result of the change in treatment? unknown".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VERITOR¿ SYSTEM FOR RAPID DETECTION OF FLU A+B CLIA-WAVED KIT
Type of Device
ANTIGENS, CF (INCLUDING CF CONTROL), INFLUENZA VIRUS A, B, C
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15739922
MDR Text Key307030713
Report Number1119779-2022-01364
Device Sequence Number1
Product Code GNX
UDI-Device Identifier00382902560456
UDI-Public00382902560456
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132692
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date10/25/2023
Device Model Number256045
Device Catalogue Number256045
Device Lot Number0321884
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/24/2022
Initial Date FDA Received11/04/2022
Supplement Dates Manufacturer Received12/05/2022
Supplement Dates FDA Received12/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/16/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-